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Software as a medical device is a relatively new 
and expanding field in which patient safety must be a 
key concern. Regulation and standards regarding 
software as a medical device (subsequently referred to 
as “SaMD”) must incorporate all components that 
could potentially influence SaMD, both in its 
development and implementation. However, SaMD 
has been varyingly defined by organisations and 
individuals within the literature, therefore there is no 
clear boundary as to what is or is not SaMD, 
consequently, no clear definition of SaMD exists. 
Without a clear definition it therefore becomes 
impossible to create standards to regulate SaMD. 
Ultimately, this results in increased risks to patient 
safety. The purpose of this study was to identify SaMD 
concepts through a Scoping Review to establish the 
boundaries of SaMD. This has significant impact on 
new technology applications to support healthcare 
monitoring and healthcare service delivery. This will 
ultimately affect how new technology can be regulated 
in healthcare and will impact innovation and design in 
this field.  
1. Introduction  
The topic of this scoping review is Software as a 
Medical Device (SaMD), which is primarily the use of 
computer software applications and mobile 
applications for health monitoring and management. 
This scoping review begins with an introduction to 
SaMD, specifically drawing attention to assessing 
current definitions. The challenges in defining the 
boundaries for SaMD and correlating these with the 
definitions, provides the context for the subsequent 
discussion of the literature.  Medical apps are an 
important component of this context and their role in 
SaMD is explored. The scoping review will also 
discuss medical device software failures, and critically 
analyse potential solutions involving standards. 
Following the introduction to SaMD, the review 
describes the methods used, the results, the outcome 
and the significance of this research.  
1.1. What is SaMD? 
The right shift in the population age distribution 
has resulted in a demand for more effective health 
systems [1]. This challenge can be addressed through 
the integration of health information systems and 
health technologies. These systems play a beneficial 
role in patient safety, can potentially reduce healthcare 
costs [2] and are supported by continuing development 
in the medical devices field [3].  Similarly, Software 
as a Medical Device, otherwise known as SaMD, is a 
growth area of health technologies, and is predicted to 
continue its expansion within the clinical environment. 
Nonetheless, a number of studies have highlighted the 
current limitations of SaMD [20]. The main constraint 
on the depth of work in this area is the lack of an 
universal definition or agreement as to what SaMD 
includes or does not include. Many of the main 
commentators in this field are concerned with this lack 
of consensus and have attempted to create a definition 
which can be agreed upon. For example, ISO/IEC 
80001 Application of risk management for IT-
networks incorporating medical devices - Part 1: 
Roles, responsibilities and activities has defined 
medical device software as a “software system that has 
been developed for the purpose of being incorporated 
into the medical device or that is intended for use as a 
medical device in its own right” [3, p.12]. This research 
does not use this definition because it specifically 
relates to software that is used within a medical device 
to function. An alternative definition which has gained 
traction, has been suggested recently by the 
International Medical Device Regulators Forum 
(IMDRF) as “software intended to be used for one or 
more medical purposes that perform without being 
part of a hardware medical device” [5, p.6]. 
Interestingly, the Australian Therapeutic Goods 
Administration, United States Food and Drug 
Administration and Canada Health reference the 
IMDRF definition and have not created their own 
definition. By comparison, organisations such as the 
regulators in the European Union, the Asian 





Harmonization Working Party, the Chinese Food and 
Drug Administration, and the Japanese Ministry of 
Health, Labour and Welfare, are currently developing 
their own SaMD definitions, standards and 
regulations.  According to the IMDRF definition, 
clinical software that assists in the diagnosis, 
treatment, prevention or mitigation of a disease is 
considered SaMD; however, it is asserted that this 
definition does not recognise medical devices that 
were previously not intended for medical purposes, 
and were unintentionally transformed into a device for 
medical purpose. Additionally, the IMDRF definition 
is not fit for purpose as it does not provide a clear 
definition for software developers and may include 
desktop information systems such as those used for 
electronic medical records (EMRs). As a result, the 
failure to develop an agreed SaMD definition has clear 
implications for the boundaries and standards of 
SaMD.  
2. The Gap in the Literature  
A review of the literature has identified gaps in 
the development of a definition of SaMD, which 
makes it difficult to assess SaMD as an effective tool 
in the delivery of healthcare. Currently, there is no 
standard definition for SaMD, and no established 
boundaries for SaMD. This consequently has direct 
impact on the development of standards for SaMD, as 
without a concise and agreed definition, affirmed 
standards cannot be aligned. This has further 
implications for the creation of new technology 
applications to support healthcare monitoring, and 
healthcare service delivery, in relation to how new 
technology can be regulated as well as the impact on 
innovation and design. Further, whilst mobile apps are 
increasingly popular, it is acknowledged that medical 
apps may not form a part of SaMD, and therefore not 
be considered regulated devices; even though they 
may be used for a medical purpose. This can have 
potentially detrimental and even fatal consequences, 
as a lack of standardisation of medical apps may result 
in no regulation of the software development lifecycle 
for such apps; ultimately, this potentially results in 
increased risks to patient safety. As a response to this 
gap, the following research question were developed.  
3. Research Questions   
1. Can a definition of SaMD be defined that 
articulates the boundaries of SaMD? 
2. What are the factors that impact the definition 
of SaMD boundaries? 
The research questions required analysis of the 
SaMD literature and references to identify if 
boundaries can be defined, as well as how they can 
assist in the creation of an agreed SaMD definition. An 
analysis of the literature on medical apps and health 
information systems was undertaken to identify the 
potential boundaries of SaMD, and how the creation 
of standards can be used in the development and use 
of SaMD. As a result, established boundaries of SaMD 
may result in a framework that could be used to assure 
patient safety when using SaMD.  
4. Research Method   
A scoping review method was chosen to answer 
the research questions, as this method provides the 
ability to identify key concepts and definitions in the 
literature [41]. Subsequently, objectives for the 
scoping review were developed from the Research 
Questions.   These were: 
• Research and analyse current literature 
on SaMD.  
• Research and identify the key elements 
of SaMD which are currently missing 
from the literature. 
• Identify the boundaries of SaMD.  
Further sub-questions were developed to assist 
with answering both the Objectives and Research 
Questions.  
• What is SaMD? 
• What are the boundaries of SaMD? 
• What are medical apps, and how do they 
relate to SaMD? 
• How is SaMD used? 
• Software failure in SaMD 
• What are the standards and solutions for 
software failure in SaMD? 
4.1. Criteria and Identifying Relevant Work  
Relevant academic articles meeting the inclusion 
criteria were used to create the categories of SaMD.  
Appropriate papers were decided on by evaluating 
each article to determine its academic quality and 
whether the content related to the area of SaMD. 
Articles that met the criteria of academic quality 
included articles that had been peer reviewed, 
published within the last 20 years, and held validity 
and reliability. It is important to note that papers older 
than 20 years were included as pre-literature, and were 
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identified as foundational papers significant to the 
research.  
Subsequently, a collection of published works 
were used to determine what components are 
mentioned and used in SaMD. The final step of the 
scoping review encompassed the identification of the 
categories to inform the boundaries of SaMD.   
 
A search term strategy, which involved searching 
the literature based on relevant key terms, was 
conducted [42]. The key search terms were derived 
from concept mapping the keywords and synonyms of 
SaMD. The following key search terms were used: 
 
• SaMD 
• Software as a Medical Device 
• Medical Device Software 
• Software as a Medical Device and 
information flow 
• Software as a Medical Device 
consequences 
• Software as a Medical Device and risks 
• Software as a Medical Device standards 
• Medical apps 
• Software as a Medical Device Security. 
4.2. Assessing Study Quality  
Literature articles in suitable databases that met 
the initial search criteria, that were content relevant 
and identified as research with rigour were identified. 
Eleven databases were searched including Proquest, 
Academic One File, and IEEE. The majority of the 
literature returned were journal articles; nonetheless 
online books, standards and published research papers 
were also examined. 
To ensure academic rigour, only articles that had 
been peer reviewed, and had met the content criteria 
were selected, and duplicate articles were eliminated.  
The search of the literature resulted in 145 journal 
articles, 124 of which were assessed as meeting the 
criteria for this scoping review.   
4.3. Summarising the Evidence  
The 124 literature articles selected were critically 
analysed and the information from these articles was 
aggregated. The outcome of aggregation resulted in 
literature categorisations based on the research sub-
questions. Table 1 provides the number of articles 
identified from the research terms. 
Remarkably, no relevant search results were 
found using key search terms “SaMD” or “medical 
device software”. Of the 124 articles selected, 43 
results originated from Proquest, 9 originated from 
Academic One file, 18 originated from IEEE, 7 
originated from Springer Link, 5 originated from 
Google Scholar, 4 originated from Science Direct, 5 
originated from Wiley Online, 4 originated from BMJ, 
2 originated from JAMA, 10 originated from PMC, 3 
originated from Taylor & Francis and 14 originated 
from other sources.  
Table 1. Articles found from the Research Terms 
5. Results  
The findings from the scoping review indicate 
that there is a lack of academic research in the 
literature using the acronym “SaMD”. It can be 
argued, SaMD is a relatively new field, which may 
explain the lack of literature to be found from this 
specific acronym term. Further, the articles analysed 
were found to have three primary themes:  Software, 
Standards and Regulation, and Risk Management. The 
next section describes the themes, and sub-themes 
identified in the literature.  
5.1. Software 
The theme Software incorporates sub-themes on 
functionality, safety and security, and lifecycle 
software development. Software, was identified as the 
Research Terms Total Articles 
SaMD 0 
 
Software as a Medical Device 37 
 




Software as a Medical Device 
information flow 
 
Software as a Medical Device 
and risks 
 




























primary theme in 83 of 124 articles. The secondary 
theme of Standards and Regulations was found in 36 
of these 83 articles, while Risk Management 
accounted for 33 of the 83 articles as a secondary 
theme.   
 
5.1.1. Functionality  
The category Functionality incorporates the 
purpose of the SaMD, the features, the implementation 
and clinical use, as well as the various types that are 
currently available or in development. Once a device 
has been created with the intention of being SaMD, the 
safety and security of the device is only considered 
post-design. Importantly, these articles highlight the 
role of software assurance, safety, security, validation, 
and verification in SaMD. Additionally, this theme 
considered the role of SaMD functionality and purpose 
through the use and workflow of SaMD.  
 
5.1.2. Safety and Security 
The safety and security of the SaMD includes the 
privacy of data, and vulnerabilities impacting 
confidentiality, availability and integrity of the data, 
including software vulnerabilities. Safety of the user 
using the device is also considered as a factor within 
this category.  
5.1.3. Software Development Lifecycle  
Once standards and regulations incorporate 
SaMD into the software development lifecycle, 
manufacturers can ensure that the design and 
manufacturing of these device are compliant with 
standards.  
5.2. Standards and Regulations  
Once vulnerabilities and threats have been 
recognised, standards and regulations can be re-
developed to include methods of addressing software 
vulnerabilities within the software development 
lifecycle. While standards and regulations were 
emphasized as a key theme in 30 of 124 of the articles, 
the articles relating to standards and regulation 
promoted frameworks that could regulate SaMD and 
discussed development of standards relating to SaMD.   
5.3. Risk Management  
Risk management can be used within the software 
development lifecycle to assess risks related to 
functionality, and to further assess risks related to the 
software deployment lifecycle itself. Risk 
management was discussed in 11 of the 124 articles, 
which emphasized the importance of regulations with 
regards to risk management.  
 
Interestingly, 7 of the 11 risk management articles 
also discussed standards and regulations, and 9 of the 
11 discussed software themes. Additionally, of the 30 
articles that discussed standards and regulations, 7 also 
discussed risk management, while 21 of the 30, 
discussed software as a secondary theme.   
 
Most significantly, the scoping review found that 
the three main themes were not mutually exclusive and 
that each article contained primary and secondary 
themes. Further analysis of the primary and secondary 
themes resulted in identification of common sub-
themes consistent across the SaMD literature. The 
sub-themes identified were:  
1. Principles, Concepts and Definitions 
2. Standards 
3. Classifications 
4. Standards created by Organisations 
5. Standards Implemented by member states 
6. Lifecycle 
7. Risk Management 
8. Hazards 
9. Consequences 




14. Models and Frameworks 
15. Validation and Verification of devices 
16. Software assurance 
17. Implementation and Clinical Use 
18. IT and Clinical Personnel 
19. Human Factors 
20. Integrity 
21. Purpose and Functionality 
22. SaMD Types 
23. Implantable 
24. Health Apps 




28. Wireless  
29. Design and Development 
These sub-themes were aggregated to the major 
themes as represented in Figure 1 and contribute to the 
understanding of SaMD components [2, 26-87]. 
Further analysis revealed what is currently missing 
from the SaMD components and. Interestingly, what 
is omitted from the literature is any comprehensive 
discussion of privacy. Hence, further research 
regarding the role of medical apps, and the impact on 
privacy is needed. The literature provides some 
indication of the boundaries of SaMD, and suggests 
that components such as privacy, software and IT 
system safety standards are highly important.  
Figure 1. Components of SaMD taken from the 
literature [2, 26-87] 
6. Discussion   
6.1. SaMD Boundaries  
Cobbaert [6] affirmed that identification of the 
intended use of SaMD can determine the boundaries 
of SaMD, and that a definition of these SaMD 
boundaries will result in a more concise definition 
which can be used to create standards. As explained by 
the literature, SaMD is complex, as there are several 
different contexts for SaMD use. The literature has 
demonstrated the multifaceted nature of SaMD and 
provides further justification to create standards that 
are suited for a rapidly evolving environment. 
Majchrowski [7] has explored both software and 
hardware contained in medical devices and has 
highlighted the importance of considering these 
aspects in the development of standards. Until now, 
the IMDRF has focused on the creation of a 
framework for regulating SaMD [8] which resulted in 
the creation of category types for devices based on 
public health impact. Hence, the IMDRF definition is 
a focused ‘regulator’ approach. This approach is not 
applicable to new innovative software and depending 
on the context, the definition may or may not be broad 
enough. Additionally, the IMDRF definition is not 
definitive and leads to interpretation, therefore, 
leading to uncertainty in the marketplace. The 
International Electrotechnical Commission (IEC) and 
the International Organization for Standardization 
(ISO) through Joint WG7 have explored establishing 
guidelines, principles, common terms and definitions 
through the development of a road map for SaMD. 
This has specific relevance to the boundaries of SaMD 
as it will result in better categorisation. In addition, 
safety risk classification [3] of SaMD can result in 
greater product safety [2]. More importantly, one of the 
most critical shortcomings of the current SaMD 
definitions and standards are the lack of distinction 
between SaMD and medical apps. The next section 
explores how SaMD is used according to the literature.  
6.2. How SaMD is Used  
The role of SaMD and how it is used within 
the clinical environment is disparate, and has yet to be 
fully explored. There is currently confusion as to what 
SaMD specifically applies and where it should be 
applied. Ellis and Watson [9] report that electronic 
records should not be classified as medical devices as 
they are data collection tools; however, other authors 
[10] differ in this view as clinical support software (for 
instance health records, patient information and billing 
information) have been claimed to assist with the 
diagnosis and treatment of patients. Such an 
assessment leads to these tools being classified as 
SaMD based on the SaMD IMDRF definition. 
Highlighted in Figure 2 are the categories and uses of 
SaMD. They include categories such as Patient 
Centred, Provider Centred and General Clinical 
Software [12, 16, 21-85]. Additionally, the literature 
provides some indication of what SaMD is, but there 
is little information on SaMD components. Other 
categories of SaMD use have been identified, which 
include; stand-alone medical devices (active medical 
devices) [11], software add-ons and computer 
controlled devices [3]. There are a variety of uses for 
SaMD technologies, some of which include remote 
surgery, intelligent operating rooms [11] real time 
sensing, gait diagnosis [12], patient management 
software [13], as well as pacemakers, defibrillators and 
infusion pumps [14]. In particular, infusion pumps 
have been widely used for therapy and diagnosis of 
patients [15]. Other uses for SaMD include sensor 
management, disease prediction, microelectronic 
components and data and device integration [12].  
While the literature has classified SaMD into three 
distinct categories, little research has been conducted 
into what role computer software, smart devices, 
medical apps [16, -17] and websites play in SaMD. Few 
studies have considered the wearable and implantable 









devices [12] and open versus proprietary clinical 
software [18] as SaMD. Therefore, further research 
into their role in patient safety and the benefits of 
SaMD is required.   
Figure 2. Categories to which the term SaMD has 
been applied [12, 16, 21-87] 
The benefits of SaMD are well-recognised with a 
reported increase in expenditure (in 2015) and 
published worth of $315 billion dollars globally [2]. 
While, 76% of SaMD deployment in 2015 was located 
in the USA, Japan, Italy and France,  the USA has the 
largest market share with $110 billion dollars spent in 
2015,  accounting for 35% of the global SaMD market 
[2]. Although SaMD represents significant benefits to 
patient safety, there is also a perceived and real risk 
when these technologies are compromised.  
 
Interestingly, only three of the 124 articles 
discussed the need for regulation of medical apps. 
However, these articles discussed SaMD regulation, 
and suggested frameworks, based on inappropriate and 
broad definitions. Further, these articles do not discuss 
the boundaries of SaMD, nor do they attempt to define 
the boundaries. In addition, the fact that only three 
articles of 124 were found to include SaMD regulatory 
frameworks suggests that research is still needed on 
this topic. The analysis of themes also revealed the 
areas of SaMD that require additional research. For 
example, there was little published on information 
flow and SaMD . Although six of the 124 articles were 
found using the search term ‘Software as Medical 
Device and information flow’, it was found that these 
articles  did not discuss how information flow is a 
factor in SaMD; therefore, further research into 
information flow and SaMD is needed in order to 
understand all the aspects of SaMD.   
 
Current risk management standards that look at 
software development, medical device manufacture 
and safety of health software, all rely upon traditional 
risk management as an essential part of the 
development process. This can be problematic as 
traditional risk management may not encompass 
modern SaMD. The optimum solution to this problem 
is the development of SaMD standards; this is 
however, not a simple and sequential process. Indeed, 
the complex and messy formulation of SaMD means 
that this is not a straightforward task when the 
boundaries of SaMD are not well defined. It was also 
found that the SaMD components are not sequentially 
linked and therefore a linear framework cannot 
provide a suitable solution. A suggested solution is for 
a framework that helps all stakeholders’ (developers, 
clinicians, and patients) understanding of how SaMD 
can be practical, safe and useful, and one which 
describes the boundaries, components and 
relationships between components. 
7. Outcome of the Scoping Review 
The primary themes of SaMD from the literature 
(refer to Section 5) were further broken down into the 
components of SaMD. This analysis resulted in 
identification of SaMD categories of use  
SaMD categories of use can be classified as: 
wireless applications, computer applications and 
medical applications. The identification of SaMD 
boundaries allows for the initial definition of SaMD 
itself.  
One specific outcome of the study was that a 
revised definition of SaMD was needed and was 
developed, as current definitions did not suitably 
reflect the boundaries of SaMD. The revised definition 
was developed by identifying the purpose of SaMD 
and what its role as a device should ideally be. The 
main purpose of SaMD is medical management, with 
patient focus as the priority. Medical management 
refers to the treatment, monitoring, prevention and 
diagnosis of the patient. Following the identification 
of SaMD’s role, the device architecture was then 
identified from the mapping of the boundaries. SaMD 
includes computer programs and other software such 
as mobile and wireless applications, which was 
included within the following initial definition.     
7.1. Revised Definition  
SaMD is standalone computer software programs 
or mobile applications that assist (treatment, 
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monitoring, prevention, diagnose) medical 
management of a patient e.g. Medical apps, clinical 
information systems. 
8. Conclusion  
A scoping review of the literature was conducted 
to identify the components and boundaries of SaMD. 
The purpose of this was to identify if a definition of 
SaMD could be described that articulated the 
boundaries of SaMD. The consensus view of the 
literature revealed that Risk Management, Standards 
and Regulations, and Software were all primary and 
secondary themes in the literature. As a primary 
theme, software was identified as including the sub-
themes of software development lifecycle, safety and 
security of data, as well as functionality. The scoping 
review also revealed that SaMD has many categories 
of use, which include clinical support software, 
diagnosis tools, treatment and assessment tools, 
standalone medical devices, software-add-ons, 
computer-controlled devices, desktop systems, 
wearable and wireless technologies and much more. 
Additionally, the overall components of SaMD can be 
classified into principles, concepts and definitions, 
design and development as well as implementation 
and clinical use.  
This research has concluded that there is no 
consensus view of what SaMD is, as the literature 
includes a broad scope that includes computer 
applications, wireless devices and medical apps. For 
example, the IMDRF define SaMD as “software 
intended to be used for one or more medical purposes 
that perform without being part of a hardware medical 
device” [5, p.6], while the European Commission’s 
Medical Devices Coordination Group has reclassified 
SaMD under their Medical Device Regulation (MDR). 
Additionally, many of the definitions of SaMD are 
contextually defined rather than properties based. 
Therefore, SaMD has no consistently defined 
boundaries as is highly contextual, and therefore could 
be considered an impractical term. This leads to 
uncertainty in the marketplace and carries an 
implication of the need for regulation to avoid the 
term. Future research needs to identify the properties 
of SaMD in order to define boundaries that can result 
in a definition that focuses on assuring patient safety 
when developing SaMD applications and using 
SaMD. The IMDRF definition of SaMD includes both 
high risk and low risk applications. Rather than use a 
context term such as SaMD, regulations should state 
what software is regulated; through use of clinical 
categories, such as EMR, patient registries, health 
records, etc. Currently, the term SaMD does not align 
with these clinical categories and results in ambiguity 
in the marketplace, resulting in difficulty in 
interpretation for vendors of the regulations as they do 
not know if their software falls within the boundaries 
of SaMD. Regulators could look to use the IEC/ISO 
82304-1 Standard [19] as a standards-based definition 
for SaMD, as this would allow both software 
developers and regulators to focus on enhanced 
clinical software safety. Further, international 
standards implementation may result in greater 
oversight for manufacturers of these devices with the 
potential to prevent patient harm as well as enhance 
privacy and security when using these devices.  
9. Significance  
This research has specifically drawn attention to 
the current lack of a consistent and consensus-based 
definition of SaMD. The challenges in defining the 
boundaries for SaMD and correlating these with the 
definitions have been highlighted and emphasises the 
need for this research. In addition, medical apps are an 
integral component of this context and their role in 
SaMD and medical device software failures needs to 
be addressed in order to suggest potential solutions 
through standards. Such standards can then be used to 
create frameworks to assure patient safety when using 
SaMD. This research will impact society by informing 
international standards development in this area as 
well as potentially the manufacturing practices of 
SaMD developers, to minimise information flow and 
interoperability issues that have the potential to lead to 
medical errors. Consequently, this will contribute to 
improved patient safety.  
 10. Ethical Considerations 
No human ethical considerations were required as 
data collection was in the form of secondary research; 
therefore, the data collected was already published and 
does not pose any risks towards animals or people. 
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